128 related articles for article (PubMed ID: 15752201)
21. Advanced glycation end products serve as ligands for lectin-like oxidized low-density lipoprotein receptor-1(LOX-1): biochemical and binding characterizations assay.
Chen X; Zhang T; Du G
Cell Biochem Funct; 2008 Oct; 26(7):760-70. PubMed ID: 18636435
[TBL] [Abstract][Full Text] [Related]
22. Intrinsic toxicity of glucose, due to non-enzymatic glycation, is controlled in-vivo by deglycation systems including: FN3K-mediated deglycation of fructosamines and transglycation of aldosamines.
Szwergold BS
Med Hypotheses; 2005; 65(2):337-48. PubMed ID: 15922110
[TBL] [Abstract][Full Text] [Related]
23. Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products.
Mera K; Nagai R; Haraguchi N; Fujiwara Y; Araki T; Sakata N; Otagiri M
Free Radic Res; 2007 Jun; 41(6):713-8. PubMed ID: 17516244
[TBL] [Abstract][Full Text] [Related]
24. Identification of CML-modified proteins in hemofiltrate of diabetic patients by proteome analysis.
Schmitt S; Linder M; Ständker L; Hammes HP; Preissner KT
Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):26-34. PubMed ID: 17926233
[TBL] [Abstract][Full Text] [Related]
25. Glycation of a lysine-containing tetrapeptide by D-glucose and D-fructose--influence of different reaction conditions on the formation of Amadori/Heyns products.
Jakas A; Katić A; Bionda N; Horvat S
Carbohydr Res; 2008 Sep; 343(14):2475-80. PubMed ID: 18656854
[TBL] [Abstract][Full Text] [Related]
26. Detection of DNA-bound advanced glycation end-products by immunoaffinity chromatography coupled to HPLC-diode array detection.
Schneider M; Georgescu A; Bidmon C; Tutsch M; Fleischmann EH; Popov D; Pischetsrieder M
Mol Nutr Food Res; 2006 Apr; 50(4-5):424-9. PubMed ID: 16598809
[TBL] [Abstract][Full Text] [Related]
27. Advanced glycation end-products prepared in solution under high pressure contain epitopes distinct from those formed in the dry reaction at high temperature.
Staniszewska M; Jarosz J; Jon M; Gamian A
Arch Immunol Ther Exp (Warsz); 2005; 53(1):71-8. PubMed ID: 15761378
[TBL] [Abstract][Full Text] [Related]
28. The MatP/matS site-specific system organizes the terminus region of the E. coli chromosome into a macrodomain.
Mercier R; Petit MA; Schbath S; Robin S; El Karoui M; Boccard F; Espéli O
Cell; 2008 Oct; 135(3):475-85. PubMed ID: 18984159
[TBL] [Abstract][Full Text] [Related]
29. Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(2):392-4. PubMed ID: 15922119
[TBL] [Abstract][Full Text] [Related]
30. Dynamic events of sister chromosomes in the cell cycle of Escherichia coli.
Adachi S; Fukushima T; Hiraga S
Genes Cells; 2008 Feb; 13(2):181-97. PubMed ID: 18233960
[TBL] [Abstract][Full Text] [Related]
31. Strategies for proteomic analysis of non-enzymatically glycated proteins.
Priego Capote F; Sanchez JC
Mass Spectrom Rev; 2009; 28(1):135-46. PubMed ID: 18949816
[TBL] [Abstract][Full Text] [Related]
32. Low-molecular weight advanced glycation end products: markers of tissue AGE accumulation and more?
Thomas MC; Forbes JM; MacIsaac R; Jerums G; Cooper ME
Ann N Y Acad Sci; 2005 Jun; 1043():644-54. PubMed ID: 16037288
[TBL] [Abstract][Full Text] [Related]
33. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.
Lunceford N; Gugliucci A
Fitoterapia; 2005 Jul; 76(5):419-27. PubMed ID: 15894431
[TBL] [Abstract][Full Text] [Related]
34. Mistranslation and genetic variability: the effect of streptomycin.
Nagel R; Chan A
Mutat Res; 2006 Oct; 601(1-2):162-70. PubMed ID: 16904706
[TBL] [Abstract][Full Text] [Related]
35. Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.
Mera K; Nagai M; Brock JW; Fujiwara Y; Murata T; Maruyama T; Baynes JW; Otagiri M; Nagai R
J Immunol Methods; 2008 May; 334(1-2):82-90. PubMed ID: 18353354
[TBL] [Abstract][Full Text] [Related]
36. Stationary phase-induction of G-->T mutations in Escherichia coli.
Shu J; Schellhorn HE; Murphy TM
Mutat Res; 2006 Apr; 596(1-2):106-12. PubMed ID: 16490219
[TBL] [Abstract][Full Text] [Related]
37. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
[TBL] [Abstract][Full Text] [Related]
38. Non-enzymatic interactions of glyoxylate with lysine, arginine, and glucosamine: a study of advanced non-enzymatic glycation like compounds.
Dutta U; Cohenford MA; Guha M; Dain JA
Bioorg Chem; 2007 Feb; 35(1):11-24. PubMed ID: 16970975
[TBL] [Abstract][Full Text] [Related]
39. Non-enzymatic glycation of human fibrillin-1.
Atanasova M; Konova E; Betova T; Baydanoff S
Gerontology; 2009; 55(1):73-81. PubMed ID: 18802325
[TBL] [Abstract][Full Text] [Related]
40. Aggregation of Escherichia coli proteins during stationary phase depends on glucose and oxygen availability.
Kwiatkowska J; Matuszewska E; Kuczyńska-Wiśnik D; Laskowska E
Res Microbiol; 2008; 159(9-10):651-7. PubMed ID: 18983914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
